American Association of Individual Investors7 天
Why Coherus BioSciences, Inc.’s (CHRS) Stock Is Down 12.59%
Coherus BioSciences, Inc.’s CHRS share price has dipped by 12.59%, which has investors questioning if this is right time to ...
American Association of Individual Investors8 天
Why Coherus BioSciences, Inc.’s (CHRS) Stock Is Up 10.66%
Coherus BioSciences, Inc.’s CHRS share price has surged by 10.66%, which has investors questioning if this is right time to sell.
Pharmaceutical Technology1 个月
CHS-114 by Coherus BioSciences for Solid Tumor: Likelihood of Approval
Coherus BioSciences (Coherus) is a commercial-stage biopharmaceutical company that focuses on research, development and commercialization of innovative immunotherapies to treat cancer. Its pipeline ...